Pfizer Is Moving Beyond Covid. Why Its Stock Is a Buy.

Pfizer probably did more than any other company to help the world normalize from the pandemic, and it reaped a financial windfall from its twin Covid-19 franchise—the top-selling vaccine and the leadi...

Powell’s in Sweden. Rates Will Likely Go Higher Still Despite Companies’ Pain.

Investors looking at Federal Reserve Chairman Jerome Powell’s speech at a conference at Sweden’s Riksbank Tuesday will be tempted to carefully parse his words for any hint as to when the interest-rate...

BioNTech upgraded to buy on high hopes for combined flu/COVID vaccine and oncology pipeline

Bank of America analysts upgraded BioNTech SE stock to buy from hold on Thursday, citing excitement about its mRNA technology and the outlook for a combined flu/COVID vaccine and oncology vaccines tha...

Pfizer’s Earnings Are Tuesday. What to Watch.

Pfizer is set to report its earnings on Tuesday, a week and a half after an executive told investors that the company was considering a list price for its Covid-19 vaccine of between $110 and $130 per...

The Oil Surplus Could Persist. Expect Prices to Fall

Text size This commentary was issued recently by money managers, research firms, and market newsletter writers and has been edited by Barron’s. Expect Oil Prices to Fall THINK Economic and Finan...

What Stocks Are Moving Monday? Tesla, Palantir, First Solar and More.

Text size Tesla shares rise early Monday. (Photo by Justin Sullivan/Getty Images) Stock futures were trading higher Monday with investors assessing how aggressive the Federal Reserve will be in its ef...

Disney, Coinbase, BioNTech, Rivian, and Other Stocks to Watch This Week

Text size Second-quarter earnings season continues this week, while a pair of July inflation figures and consumer sentiment surveys will be the highlights on the economic-data calendar. On Monday, Tys...

Disney, Coinbase, BioNTech, Rivian, and Other Stocks for Investors to Watch This Week

Text size Second-quarter earnings season continues this week, while a pair of July inflation figures and consumer sentiment surveys will be the highlights on the economic-data calendar. On Monday, Tys...

BNTX Stock: Why ‘Covid Fatigue’ Isn’t Enough To Keep BioNTech Down

BioNTech (BNTX) snagged an upgrade Wednesday with an analyst saying “Covid fatigue” has obscured its non-pandemic efforts. BNTX stock jumped on the news. X SVB Securities analyst Daina Gra...

Pfizer Raises Covid-19 Vaccine Price 27%. What It Means for the Stock.

Text size Pfizer said it has signed a deal to supply the U.S. with vaccines in the fall, while Moderna has yet to announce a sale. Jacob King – WPA Pool / Getty Images Pfizer has raised the U.S....

The Russian Default Is Less Worrisome Than It Appears. Keep Watching Oil.

A general view of the Kremlin, Red Square and St. Basil’s Cathedral in central Moscow. AFP via Getty Images Text size Russia’s first default on its foreign debt in more than 100 years is the lat...

Novavax’s New Covid-19 Vaccine Might Be Late to the Party

It’s one thing to arrive fashionably late to a party, it’s another thing to waltz in when the last guests are stumbling out the door. For Novavax , which on Tuesday cleared a key step toward U.S. Food...

Relief at the Pump Could Come Soon. Thank Saudi Arabia.

Justin Sullivan/Getty Images Text size Oil prices fell Thursday after the Financial Times reported that Saudi Arabia was ready to increase output as more sanctions on Russia threaten global oil supply...

Novavax Gets a Sell Rating. It’s Got a Covid Vaccine Problem, Analyst Says.

Text size A healthcare worker prepares a dose of Nuvaxovid vaccine. Jeroen Jumelet/ANP/AFP via Getty Images Novavax stock was dropping Friday after receiving a Sell-equivalent rating — the first since...

BioNTech Earnings Top Forecasts on Strong Sales of Covid-19 Vaccine

Text size BioNTech is continuing to work with Pfizer on follow-on Covid-19 vaccines. (Photo by THOMAS LOHNES/AFP via Getty Images) BioNTech , the German biotech company, reported first-quarter earning...

Pfizer’s New CFO David Denton Negotiated One of the Biggest Healthcare Deals in History

Pfizer on Monday named a new chief financial officer with a resume that hints at the company’s plans to spend big with its Covid-19 vaccine windfall. David Denton is taking up the CFO role at Pfizer (...

Pfizer Stock Is Falling. Did Investors Misunderstand the Revenue Guidance?

Pfizer CEO Albert Bourla talks. John Thys/Pool/AFP/Getty Images Text size Pfizer shares dropped sharply after the company’s 2022 sales guidance appeared to fall short of expectations. The guidance tha...

Pfizer Stock Fell 2.8%. Did Investors Misunderstand the Revenue Guidance?

Text size Pfizer CEO Albert Bourla talks. John Thys/Pool/AFP/Getty Images Pfizer shares dropped sharply on Tuesday after the company’s 2022 sales guidance appeared to fall short of expectations. The g...

Pfizer stock falls after profit beats but revenue misses, even as COVID-19 vaccine sales of $12.5 billion top forecasts

Shares of Pfizer Inc. PFE, +0.40% sank 2.6% in premarket trading Tuesday, after the drug maker reported fourth-quarter profit that beat expectations, while revenue more than doubled but missed forecas...

Pfizer Reports Earnings Tuesday. What to Expect.

Text size Pfizer is scheduled to report its earnings before the market opens on Tuesday. Jeenah Moon/Getty Images There’s no mystery about what 2022 will bring for Pfizer : Enormous, record-shattering...

It’s Time to Bargain Hunt. 27 Picks to Beat the Stock Market From Barron’s Roundtable Experts.

“There is no easier way to make money in the market than to buy a great company under pressure due to short-term concerns.” So said the newest member of the Barron’s Roundtable, David Giroux of T. Row...

Johnson & Johnson’s got a new CEO and a plan to split the company in two. Here’s what else to expect out of J&J’s earnings

Johnson & Johnson JNJ, -0.31% has long been viewed as a bellwether stock for other health care companies, given its early slot in the earnings calendar and a business model that spans everything f...

Moderna and Novavax Stocks Get Whacked by Supreme Court’s Vaccine Decision

Text size A nurse takes a Moderna Covid-19 vaccines ready to be administered at a vaccination site Apu Gomes/AFP via Getty Images Novavax stock and shares of other vaccine makers fell Friday after the...